| Literature DB >> 25083125 |
Abstract
Albiglutide (Tanzeum) for type-2 diabetes, ramucirumab (Cyramza) for advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma, and ceritinib (Zykadia) for metastatic non-small-cell lung cancer.Entities:
Year: 2014 PMID： 25083125 PMCID： PMC4103573
Source DB: PubMed Journal: P T ISSN： 1052-1372